Pulmonx Corp Income Statement
LUNG|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Pulmonx Corp reported $84M in revenue and $56M in net loss for FY2025. Revenue has grown at a 33.2% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $83.8M | $68.7M | $53.7M | $48.4M | $32.7M | $20.0M |
| Cost of Revenue | $21.8M | $17.9M | $13.8M | $12.8M | $11.5M | $7.7M |
| Gross Profit | $62.0M | $50.8M | $39.9M | $35.6M | $21.2M | $12.3M |
| SG&A Expense | $102.1M | $94.6M | $83.1M | $69.9M | $46.1M | $20.3M |
| R&D Expense | $17.6M | $18.1M | $15.4M | $13.1M | $7.5M | $7.0M |
| Operating Income | -$57.7M | -$61.9M | -$58.6M | -$47.3M | -$32.3M | -$15.1M |
| Interest Expense | - | - | $1.1M | $829.0K | $3.2M | $2.5M |
| Income Tax | $500.0K | $571.0K | $353.0K | $343.0K | $213.0K | $12.0K |
| Net Income | -$56.4M | -$60.8M | -$58.9M | -$48.7M | -$32.2M | -$18.5M |
| EPS (Basic) | -$1.44 | -$1.60 | -$1.59 | -$1.35 | -$3.16 | - |
| EPS (Diluted) | -$1.44 | -$1.60 | -$1.59 | -$1.35 | -$3.16 | -$11.03 |
| Shares Outstanding | 39.8M | 38.5M | 37.6M | 36.9M | 35.7M | 2.1M |
| Gross Margin | 74.0% | 73.9% | 74.3% | 73.6% | 64.8% | 61.4% |
| Operating Margin | -68.9% | -90.2% | -109.3% | -97.7% | -98.8% | -75.2% |
| Profit Margin | -67.3% | -88.6% | -109.8% | -100.5% | -98.5% | -92.4% |